US - Neurodiagnostic and Monitoring Devices Market by Product, End-user, and Application - Forecast and Analysis 2024-2028

Published: Oct 2023 Pages: 165 SKU: IRTNTR40602

US - Neurodiagnostic and Monitoring Devices Market 2024-2028

The US - neurodiagnostic and monitoring devices market size is estimated to grow by USD 827.88 million at a CAGR of 6.19% between 2023 and 2028. 

Due to the increased prevalence of brain disorders, there is an increase in demand for EEG procedures. In order to diagnose a large number of neurological disorders, an EEG test is essential. Moreover, EEG devices are also being increasingly used for other applications such as cognitive health and well-being, sleep quality improvement, and stress reduction. The increasing demand for EEG devices for the diagnosis of neurological disorders drives the adoption of EEG devices in the country. Hence, the rising demand for EEG procedures will propel the growth of the market during the forecast period.

Technavio has segmented the market into Product, End-user, and Application

  • The product segment includes ICP monitoring devices, EEG devices, EMG devices, and others
  • The end-user segment includes hospitals, clinics, and laboratories
  • The application segment includes stroke, migraine, epilepsy, parkinsons disease, and ischemic stroke

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 to 2022, besides analyzing the current market scenario.

What will be the size of the US Neurodiagnostic and Monitoring Devices Market During the Forecast Period?

To learn more about this report, Request Free Sample

US Neurodiagnostic and Monitoring Devices Market Segmentation by Product, End-user, and Application Analysis

Product  Analysis 

ICP Monitoring devices

The market share growth by the ICP monitoring devices segment will be significant during the forecast period. The introduction of ICP devices in the market is stimulated by factors like an increased incidence of traumatic brain injury, cases of BTI and brain tumors, a rise in product launches as well a strong market player presence. Moreover, market players are developing various business strategies that will boost the adoption of ICP devices. The number of pure-play players is increasing in the market due to the growing number of product launches.

Get a glance at the market contribution of various segments View a PDF Sample

The ICP monitoring devices segment was valued at USD 713.58 million in 2018. The demand for both invasive and non-invasive techniques for ICP monitoring is growing. Transcranial Doppler (TCD) is used to estimate ICP non-invasively. TCD helps to detect the changes in cerebrovascular dynamics. Owing to the growing demand for TCD, players are concentrating on launching new products in the US - neurodiagnostic and monitoring devices market. Thus, the increased benefit of ICP monitoring devices will drive the growth of the market during the forecast period.

End-user Analysis

Hospitals

Hospitals have cutting-edge medical equipment to detect/analyze the most critical cases and conduct surgeries. They have state-of-the-art infrastructure, which caters to the growing demand of physicians and patients. In addition, many reimbursement authorities and government organizations tie up with hospitals to provide treatment to patients. Furthermore, due to the increase in the target population requiring surgeries for treating a broad range of acute and chronic diseases, there will be a steady increase in the demand for neurodiagnostic and monitoring devices, which in turn will drive the growth of the neurodiagnostic and monitoring devices market in the US in the hospitals segment during the forecast period.

Clinics

Privately run clinic-based reference labs and diagnostic centers are laboratories that provide diagnostics and testing services to clinics. These types of reference diagnostic centers usually get references from small clinics, healthcare professional's offices, and nursing homes. Furthermore, market players are developing portable and compact neurodiagnostic and monitoring devices. The availability of these devices will increase the revenue of this segment by 2025. Advancements in technology, leading to the development of innovative products that deliver fast and timely treatment solutions, will also increase the growth rate of the US - neurodiagnostic and monitoring devices market in the clinics segment during the forecast period.

Buy Now Full Report and Discover More

Key US Neurodiagnostic and Monitoring Devices Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Advanced Brain Monitoring Inc.: The company offers neurodiagnostics and monitoring devices such as Stat X series mobile EEG systems and B Alert systems.

  • Ambu AS
  • Bio Signal Group Corp.
  • Cadwell Industries Inc.
  • Compumedics Ltd.
  • Delsys Inc.
  • ELMIKO BIOSIGNALS sp. z o.o.
  • General Electric Co.
  • Jordan NeuroScience
  • Koninklijke Philips N.V.
  • Lifelines Neuro Company LLC
  • Masimo Corp.
  • Medtronic Plc
  • Motion Lab Systems Inc
  • Natus Medical Inc.
  • neurocare group AG
  • Nihon Kohden Corp.
  • NovaSignal Corp.
  • RAUMEDIC AG
  • Viasonix Ltd

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

US Neurodiagnostic and Monitoring Devices Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Key US Neurodiagnostic and Monitoring Devices Market Drivers

Increasing incidences and prevalence of neurological conditions is the key factor driving market growth. Patients with a comprehensive range of neurological disorders, including epilepsy, stroke, Parkinsons disease, and brain tumors, have a high risk of developing a disability. These neurological disorders develop due to various factors such as bacterial and viral infections, genetic factors, and the lack of immune response. Healthcare professionals use neurodiagnostic and monitoring devices such as EEG, EMG, MEG, and ICP to diagnose neurological diseases for further interventions to save the lives of the patients.

Furthermore, a stroke can lead to malignant cerebral edema, which leads to inadequate blood flow. This increases intracranial pressure and brain shift, causing herniation syndrome leading to brain death. In such cases, ICP monitoring devices are used to measure intracranial pressure. Therefore, the increasing number of stroke cases in the US will boost the growth of the market during the forecast period.

Significant US Neurodiagnostic and Monitoring Devices Market Trends

The paradigm shift toward a hybrid brain-computer interface is the primary trend shaping market growth. The demand for non-invasive, hybrid brain-computer interface (HBCI) technologies has grown for enhancing the accuracy of neurodiagnostic procedures. EEG is a broadly accepted and mainly performed procedure for diagnosis purposes. It is mostly used in combination with other modalities, such as EMG and PSG, to enhance the number of control commands, enhance accuracy, and undervalue the signal detection time. The prominent market players are focusing on using HBCI technologies in the development of technologically advanced products for the diagnosis of various neurological diseases. 

Moreover, the hybridization of MEG with MRI is under development. For example, the European Union is focusing on the development of a hybrid imaging scanner that combines MEG and MRI technology and allows structural MRI and functional MEG imaging of the human brain. Hence, the paradigm shift towards a hybrid brain-computer interface will propel the growth of the neurodiagnostic and monitoring devices market in the US during the forecast period.

Major US Neurodiagnostic and Monitoring Devices Market Challenges

Complications related to neurodiagnostic procedures and monitoring is a challenge that affects market growth. EEG devices are mainly used to count the electrical activity of the brain. EEG is an adequate technique with no side effects and is performed by qualified healthcare specialists. In specific cases, patients with epilepsy undergoing the procedure may experience a seizure, which can lead to various medical complications. Seizures triggered by various factors during the EEG procedure, including flashing lights, can lead to false results.

Furthermore, the risks and complications associated with standard neurodiagnostic and monitoring devices can enhance the adoption of alternatives. Therefore, the presence of alternative treatment options is expected to impede the growth of the US neurodiagnostic and monitoring devices market to a certain extent during the forecast period.

Buy Now Full Report and Discover More

Key US Neurodiagnostic and Monitoring Devices Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

US Neurodiagnostic and Monitoring Devices Market Customer Landscape

Segment Overview

The US neurodiagnostic and monitoring devices market report forecasts market growth by revenue and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • Product Outlook (USD Million, 2018-2028)
    • ICP Monitoring devices
    • EEG devices
    • EMG devices
    • Others
  • End-user Outlook (USD Million, 2018-2028)
    • Hospitals
    • Clinics
    • Laboratories
  • Application Outlook (USD Million, 2018-2028)
    • Stroke
    • Migraine
    • Epilepsy
    • Parkinsons disease
    • Ischemic stroke

US Neurodiagnostic and Monitoring Devices Market Scope

Report Coverage

Details

Page number

165

Base year

2023

Historic period

2018 - 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 6.19%

Market Growth 2024-2028

USD 827.88 million

Market structure

Fragmented

YoY growth 2023-2024(%)

5.24

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Advanced Brain Monitoring Inc., Ambu AS, Bio Signal Group Corp., Cadwell Industries Inc., Compumedics Ltd., Delsys Inc., ELMIKO BIOSIGNALS sp. z o.o., General Electric Co., Jordan NeuroScience, Koninklijke Philips N.V., Lifelines Neuro Company LLC, Masimo Corp., Medtronic Plc, Motion Lab Systems Inc, Natus Medical Inc., neurocare group AG, Nihon Kohden Corp., NovaSignal Corp., RAUMEDIC AG, and Viasonix Ltd

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this US Neurodiagnostic and Monitoring Devices Market Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the US neurodiagnostic and monitoring devices market between 2024 and 2028
  • Precise estimation of the size of the US neurodiagnostic and monitoring devices market size and its contribution of the market in focus to the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across US
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of US neurodiagnostic and monitoring devices market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Country Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 08: Parent market
    • Exhibit 09: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 10: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 11: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 12: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 13: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 14: Chart on US: Year-over-year growth 2023-2028 (%)
      • Exhibit 15: Data Table on US: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Neurodiagnostic and monitoring devices market in US 2018 - 2022
      • Exhibit 16: Historic Market Size – Data Table on neurodiagnostic and monitoring devices market in US 2018 - 2022 ($ million)
    • 4.2 Product Segment Analysis 2018 - 2022
      • Exhibit 17: Historic Market Size – Product Segment 2018 - 2022 ($ million)
    • 4.3 End-user Segment Analysis 2018 - 2022
      • Exhibit 18: Historic Market Size – End-user Segment 2018 - 2022 ($ million)
    • 4.4 Application Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 20: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 21: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 22: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 23: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 24: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 25: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 26: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 27: Chart on Product - Market share 2023-2028 (%)
      • Exhibit 28: Data Table on Product - Market share 2023-2028 (%)
    • 6.2 Comparison by Product
      • Exhibit 29: Chart on Comparison by Product
      • Exhibit 30: Data Table on Comparison by Product
    • 6.3 ICP Monitoring devices - Market size and forecast 2023-2028
      • Exhibit 31: Chart on ICP Monitoring devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 32: Data Table on ICP Monitoring devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 33: Chart on ICP Monitoring devices - Year-over-year growth 2023-2028 (%)
      • Exhibit 34: Data Table on ICP Monitoring devices - Year-over-year growth 2023-2028 (%)
    • 6.4 EEG devices - Market size and forecast 2023-2028
      • Exhibit 35: Chart on EEG devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Data Table on EEG devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 37: Chart on EEG devices - Year-over-year growth 2023-2028 (%)
      • Exhibit 38: Data Table on EEG devices - Year-over-year growth 2023-2028 (%)
    • 6.5 EMG devices - Market size and forecast 2023-2028
      • Exhibit 39: Chart on EMG devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Data Table on EMG devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 41: Chart on EMG devices - Year-over-year growth 2023-2028 (%)
      • Exhibit 42: Data Table on EMG devices - Year-over-year growth 2023-2028 (%)
    • 6.6 Others - Market size and forecast 2023-2028
      • Exhibit 43: Chart on Others - Market size and forecast 2023-2028 ($ million)
      • Exhibit 44: Data Table on Others - Market size and forecast 2023-2028 ($ million)
      • Exhibit 45: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 46: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 6.7 Market opportunity by Product
      • Exhibit 47: Market opportunity by Product ($ million)
      • Exhibit 48: Data Table on Market opportunity by Product ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 49: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 50: Data Table on End-user - Market share 2023-2028 (%)
    • 7.2 Comparison by End-user
      • Exhibit 51: Chart on Comparison by End-user
      • Exhibit 52: Data Table on Comparison by End-user
    • 7.3 Hospitals - Market size and forecast 2023-2028
      • Exhibit 53: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 55: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Exhibit 56: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 7.4 Clinics - Market size and forecast 2023-2028
      • Exhibit 57: Chart on Clinics - Market size and forecast 2023-2028 ($ million)
      • Exhibit 58: Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
      • Exhibit 59: Chart on Clinics - Year-over-year growth 2023-2028 (%)
      • Exhibit 60: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
    • 7.5 Laboratories - Market size and forecast 2023-2028
      • Exhibit 61: Chart on Laboratories - Market size and forecast 2023-2028 ($ million)
      • Exhibit 62: Data Table on Laboratories - Market size and forecast 2023-2028 ($ million)
      • Exhibit 63: Chart on Laboratories - Year-over-year growth 2023-2028 (%)
      • Exhibit 64: Data Table on Laboratories - Year-over-year growth 2023-2028 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 65: Market opportunity by End-user ($ million)
      • Exhibit 66: Data Table on Market opportunity by End-user ($ million)

    8 Market Segmentation by Application

    • 8.1 Market segments
      • Exhibit 67: Chart on Application - Market share 2023-2028 (%)
      • Exhibit 68: Data Table on Application - Market share 2023-2028 (%)
    • 8.2 Comparison by Application
      • Exhibit 69: Chart on Comparison by Application
      • Exhibit 70: Data Table on Comparison by Application
    • 8.3 Stroke - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Stroke - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on Stroke - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on Stroke - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Stroke - Year-over-year growth 2023-2028 (%)
    • 8.4 Migraine - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Migraine - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Migraine - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Migraine - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Migraine - Year-over-year growth 2023-2028 (%)
    • 8.5 Epilepsy - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Epilepsy - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on Epilepsy - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on Epilepsy - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Epilepsy - Year-over-year growth 2023-2028 (%)
    • 8.6 Parkinsons disease - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on Parkinsons disease - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Parkinsons disease - Year-over-year growth 2023-2028 (%)
    • 8.7 Ischemic stroke - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Ischemic stroke - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on Ischemic stroke - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on Ischemic stroke - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Ischemic stroke - Year-over-year growth 2023-2028 (%)
    • 8.8 Market opportunity by Application
      • Exhibit 91: Market opportunity by Application ($ million)
      • Exhibit 92: Data Table on Market opportunity by Application ($ million)

    9 Customer Landscape

    • 9.1 Customer landscape overview
      • Exhibit 93: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 94: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 95: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 96: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 97: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 98: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 99: Matrix on vendor position and classification
            • 12.3 Advanced Brain Monitoring Inc.
              • Exhibit 100: Advanced Brain Monitoring Inc. - Overview
              • Exhibit 101: Advanced Brain Monitoring Inc. - Key offerings
            • 12.4 Ambu AS
              • Exhibit 102: Ambu AS - Overview
              • Exhibit 103: Ambu AS - Business segments
              • Exhibit 104: Ambu AS - Key offerings
              • Exhibit 105: Ambu AS - Segment focus
            • 12.5 Bio Signal Group Corp.
              • Exhibit 106: Bio Signal Group Corp. - Overview
              • Exhibit 107: Bio Signal Group Corp. - Product / Service
              • Exhibit 108: Bio Signal Group Corp. - Key offerings
            • 12.6 Cadwell Industries Inc.
              • Exhibit 109: Cadwell Industries Inc. - Overview
              • Exhibit 110: Cadwell Industries Inc. - Product / Service
              • Exhibit 111: Cadwell Industries Inc. - Key offerings
            • 12.7 Compumedics Ltd.
              • Exhibit 112: Compumedics Ltd. - Overview
              • Exhibit 113: Compumedics Ltd. - Product / Service
              • Exhibit 114: Compumedics Ltd. - Key offerings
            • 12.8 Delsys Inc.
              • Exhibit 115: Delsys Inc. - Overview
              • Exhibit 116: Delsys Inc. - Product / Service
              • Exhibit 117: Delsys Inc. - Key offerings
            • 12.9 ELMIKO BIOSIGNALS sp. z o.o.
              • Exhibit 118: ELMIKO BIOSIGNALS sp. z o.o. - Overview
              • Exhibit 119: ELMIKO BIOSIGNALS sp. z o.o. - Product / Service
              • Exhibit 120: ELMIKO BIOSIGNALS sp. z o.o. - Key offerings
            • 12.10 General Electric Co.
              • Exhibit 121: General Electric Co. - Overview
              • Exhibit 122: General Electric Co. - Business segments
              • Exhibit 123: General Electric Co. - Key news
              • Exhibit 124: General Electric Co. - Key offerings
              • Exhibit 125: General Electric Co. - Segment focus
            • 12.11 Koninklijke Philips N.V.
              • Exhibit 126: Koninklijke Philips N.V. - Overview
              • Exhibit 127: Koninklijke Philips N.V. - Business segments
              • Exhibit 128: Koninklijke Philips N.V. - Key news
              • Exhibit 129: Koninklijke Philips N.V. - Key offerings
              • Exhibit 130: Koninklijke Philips N.V. - Segment focus
            • 12.12 Lifelines Neuro Company LLC
              • Exhibit 131: Lifelines Neuro Company LLC - Overview
              • Exhibit 132: Lifelines Neuro Company LLC - Product / Service
              • Exhibit 133: Lifelines Neuro Company LLC - Key offerings
            • 12.13 Masimo Corp.
              • Exhibit 134: Masimo Corp. - Overview
              • Exhibit 135: Masimo Corp. - Product / Service
              • Exhibit 136: Masimo Corp. - Key offerings
            • 12.14 Medtronic Plc
              • Exhibit 137: Medtronic Plc - Overview
              • Exhibit 138: Medtronic Plc - Business segments
              • Exhibit 139: Medtronic Plc - Key news
              • Exhibit 140: Medtronic Plc - Key offerings
              • Exhibit 141: Medtronic Plc - Segment focus
            • 12.15 Natus Medical Inc.
              • Exhibit 142: Natus Medical Inc. - Overview
              • Exhibit 143: Natus Medical Inc. - Product / Service
              • Exhibit 144: Natus Medical Inc. - Key news
              • Exhibit 145: Natus Medical Inc. - Key offerings
            • 12.16 Nihon Kohden Corp.
              • Exhibit 146: Nihon Kohden Corp. - Overview
              • Exhibit 147: Nihon Kohden Corp. - Product / Service
              • Exhibit 148: Nihon Kohden Corp. - Key news
              • Exhibit 149: Nihon Kohden Corp. - Key offerings
            • 12.17 Viasonix Ltd
              • Exhibit 150: Viasonix Ltd - Overview
              • Exhibit 151: Viasonix Ltd - Product / Service
              • Exhibit 152: Viasonix Ltd - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 153: Inclusions checklist
                • Exhibit 154: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 155: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 156: Research methodology
                • Exhibit 157: Validation techniques employed for market sizing
                • Exhibit 158: Information sources
              • 13.5 List of abbreviations
                • Exhibit 159: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              neurodiagnostic and monitoring devices market

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis